705 related articles for article (PubMed ID: 16887890)
1. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
Petrakis IL; Nich C; Ralevski E
Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
[TBL] [Abstract][Full Text] [Related]
4. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
Green AI
J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
[TBL] [Abstract][Full Text] [Related]
5. The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders.
Ralevski E; Ball S; Nich C; Limoncelli D; Petrakis I
Am J Addict; 2007; 16(6):443-9. PubMed ID: 18058408
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder.
Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Ralevski E; Rounsaville B
Biol Psychiatry; 2006 Oct; 60(7):777-83. PubMed ID: 17008146
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans.
Arias AJ; Gelernter J; Gueorguieva R; Ralevski E; Petrakis IL
Am J Addict; 2014; 23(3):288-93. PubMed ID: 24724887
[TBL] [Abstract][Full Text] [Related]
8. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
Baser O; Chalk M; Rawson R; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
[TBL] [Abstract][Full Text] [Related]
9. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
Buri C; Moggi F; Giovanoli A; Strik W
Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in veterans with alcohol dependence and co-occurring mental illness.
Ralevski E; Gianoli MO; McCarthy E; Petrakis I
Addict Behav; 2014 Feb; 39(2):386-91. PubMed ID: 23890764
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone in patients with bipolar disorder and alcohol dependence.
Brown ES; Beard L; Dobbs L; Rush AJ
Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.
Petrakis IL; O'Malley S; Rounsaville B; Poling J; McHugh-Strong C; Krystal JH;
Psychopharmacology (Berl); 2004 Mar; 172(3):291-7. PubMed ID: 14634716
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of alcohol use disorders.
Buonopane A; Petrakis IL
Subst Use Misuse; 2005; 40(13-14):2001-20, 2043-8. PubMed ID: 16282090
[TBL] [Abstract][Full Text] [Related]
14. A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.
Pettinati HM; Kampman KM; Lynch KG; Xie H; Dackis C; Rabinowitz AR; O'Brien CP
Addict Behav; 2008 May; 33(5):651-67. PubMed ID: 18079068
[TBL] [Abstract][Full Text] [Related]
15. Manic episode with psychotic symptoms associated with high dose of disulfiram: a case report.
Ceylan ME; Turkcan A; Mutlu E; Onal O
J Clin Psychopharmacol; 2007 Apr; 27(2):224-5. PubMed ID: 17414256
[No Abstract] [Full Text] [Related]
16. Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features.
Grant JE; Potenza MN; Kraus SW; Petrakis IL
J Clin Psychiatry; 2017; 78(9):e1299-e1306. PubMed ID: 29345864
[TBL] [Abstract][Full Text] [Related]
17. [Drugs against alcohol abuse].
Mørland J
Tidsskr Nor Laegeforen; 2006 Dec; 126(24):3268-9. PubMed ID: 17170774
[No Abstract] [Full Text] [Related]
18. Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.
Sajatovic M; Friedman SH; Sabharwal J; Bingham CR
J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):3-8. PubMed ID: 15018690
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
Wobrock T; D'Amelio R; Falkai P
Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
[TBL] [Abstract][Full Text] [Related]
20. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]